Shares of Eli Lilly (NYSE: LLY) fell sharply on Thursday, dropping more than 11% in regular trading after the company
9 months ago
Drugmakers will ask the U.S. government to pause price negotiations for prescription drugs, Bloomberg News reported on Monday, citing Eli
1 year ago
The U.S. Food and Drug Administration has revoked the emergency use authorization for four COVID-19 antibody-based drugs, including those from
On Friday, the U.S. Food and Drug Administration approved Eli Lilly’s (NYSE: LLY) weight-loss treatment, Zepbound, for obstructive sleep apnea,
SHANGHAI – As Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) expand sales of their popular diabetes and weight-loss
LONDON – Britons paying privately for obesity drugs are increasingly choosing Eli Lilly’s (NYSE: LLY) Mounjaro over Novo Nordisk’s (NYSE:
President-elect Donald Trump met with the chief executives of U.S. drugmakers Pfizer (NYSE: PFE) and Eli Lilly (NYSE: LLY) as
COPENHAGEN – Shares of weight-loss drug makers Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) rose on Tuesday after
Americans are still eagerly seeking prescriptions for Eli Lilly’s (NYSE: LLY) and Novo Nordisk’s (NYSE: NVO) weight-loss and diabetes drugs
NEW YORK – Most U.S. states do not currently cover highly sought-after weight-loss drugs from Novo Nordisk (NYSE: NVO) and
LONDON – Britain will study whether the use of Eli Lilly’s (NYSE: LLY) weight loss drug can get people back
On Monday, a drug compounding industry group sued the U.S. Food and Drug Administration over its decision to take Eli
